Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-02-27 @ 4:06 PM
Study NCT ID:
NCT00552058
Status:
COMPLETED
Last Update Posted:
2018-08-09
First Post:
2007-10-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Sponsor:
UCB Pharma
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Crohn Disease | View |